Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Jun Song

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Clinical Nuclear Medicine|May 23, 2012
Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinomaHong-Jun Song, Chun-Gen Wu, Yan-Li Xue, et al.
Frontiers in Endocrinology|January 31, 2020
Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic IndicatorsZhong-Ling Qiu, Chen-Tian Shen, Zhen-Kui Sun, et al.
Endocrine|March 4, 2019
Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the diseaseChen-Tian Shen, Guo-Qiang Zhang, Zhong-Ling Qiu, et al.
Nature|May 3, 2002
Adaptation in the chemotactic guidance of nerve growth conesGuo-li Ming, Scott T Wong, John Henley, et al.
Cancer Science|November 28, 2020
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancerGuo-Qiang Zhang, Qiong Jiao, Chen-Tian Shen, et al.
International Journal of Endocrinology|March 21, 2022
Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma PatientsChuang Xi, Guo-Qiang Zhang, Hong-Jun Song, et al.
Endocrine|March 20, 2020
Distant metastases from pathologically proven benign follicular nodules of the thyroid: clinicopathological features and predictors of long-term survivalZhong-Ling Qiu, Chen-Tian Shen, Zhen-Kui Sun, et al.
Scientific Reports|June 8, 2017
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative <sup>131</sup>I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb LevelZhong-Ling Qiu, Wei-Jun Wei, Chen-Tian Shen, et al.
Oncotarget|October 21, 2017
Dual time-point <sup>18</sup>F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesionsChen-Tian Shen, Zhong-Ling Qiu, Zhen-Kui Sun, et al.
Journal of Molecular Endocrinology|December 7, 2016
Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivoChen-Tian Shen, Wei-Jun Wei, Zhong-Ling Qiu, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Clinical Nuclear Medicine|May 23, 2012
Percutaneous osteoplasty combined with radioiodine therapy as a treatment for bone metastasis developing after differentiated thyroid carcinomaHong-Jun Song, Chun-Gen Wu, Yan-Li Xue, et al.
Frontiers in Endocrinology|January 31, 2020
Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic IndicatorsZhong-Ling Qiu, Chen-Tian Shen, Zhen-Kui Sun, et al.
Endocrine|March 4, 2019
Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the diseaseChen-Tian Shen, Guo-Qiang Zhang, Zhong-Ling Qiu, et al.
Nature|May 3, 2002
Adaptation in the chemotactic guidance of nerve growth conesGuo-li Ming, Scott T Wong, John Henley, et al.
Cancer Science|November 28, 2020
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancerGuo-Qiang Zhang, Qiong Jiao, Chen-Tian Shen, et al.
International Journal of Endocrinology|March 21, 2022
Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma PatientsChuang Xi, Guo-Qiang Zhang, Hong-Jun Song, et al.
Endocrine|March 20, 2020
Distant metastases from pathologically proven benign follicular nodules of the thyroid: clinicopathological features and predictors of long-term survivalZhong-Ling Qiu, Chen-Tian Shen, Zhen-Kui Sun, et al.
Scientific Reports|June 8, 2017
Diagnostic Performance of <sup>18</sup>F-FDG PET/CT in Papillary Thyroid Carcinoma with Negative <sup>131</sup>I-WBS at first Postablation, Negative Tg and Progressively Increased TgAb LevelZhong-Ling Qiu, Wei-Jun Wei, Chen-Tian Shen, et al.
Oncotarget|October 21, 2017
Dual time-point <sup>18</sup>F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesionsChen-Tian Shen, Zhong-Ling Qiu, Zhen-Kui Sun, et al.
Journal of Molecular Endocrinology|December 7, 2016
Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivoChen-Tian Shen, Wei-Jun Wei, Zhong-Ling Qiu, et al.
Pageof 7